Also trades as: INFI (NASDAQ) · $vol 0M
INFIQ OTC
Infinity Pharmaceuticals, Inc.
1W: -99.0%
1M: -99.0%
3M: +0.0%
YTD: -99.0%
1Y: -98.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±9113.7%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$3M
+39.6% ▲
3Y CAGR: -5.3%
Gross Profit
$1M
+39.6% ▲
Operating Income
-$45M
+0.5% ▲
Net Income
-$44M
+2.0% ▲
EPS (Diluted)
$-0.50
+5.7% ▲
EBITDA
-$44M
+2.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $3M | $2M | $2M | $3M |
| YoY Growth | +0.0% | -43.6% | +8.1% | +39.6% |
| Cost of Revenue | $7M | $1M | $1M | $2M |
| Gross Profit | -$4M | $682K | $738K | $1M |
| Gross Margin | -139.7% | 39.7% | 39.7% | 39.7% |
| R&D Expenses | $27M | $27M | $32M | $32M |
| SG&A Expenses | $14M | $12M | $14M | $13M |
| Operating Expenses | $41M | $39M | $46M | $46M |
| Operating Income | -$46M | -$38M | -$45M | -$45M |
| Operating Margin | -1497.7% | -2239.5% | -2426.4% | -1729.4% |
| Interest Expense | $3M | $2M | $180K | $180K |
| Income Before Tax | -$47M | -$40M | -$45M | -$44M |
| Tax Expense | -$54K | $0 | $0 | $0 |
| Net Income | -$47M | -$40M | -$45M | -$44M |
| Net Margin | -1543.4% | -2355.6% | -2436.1% | -1711.1% |
| EPS (Diluted) | $-0.83 | $-0.68 | $-0.53 | $-0.50 |
| EBITDA | -$44M | -$38M | -$45M | -$44M |
| Shares Outstanding | 57M | 60M | 86M | 89M |